Thomas D O'Halloran

Papers

Total Citations

H-Index

About

Thomas D. O’Halloran is a urologic surgeon and researcher whose work focuses on the safety and outcomes of minimally invasive kidney surgery, particularly robotic partial nephrectomy. His most-cited study, “Aspirin and clopidogrel during robotic partial nephrectomy, is it safe?” (2015, 6 citations), addresses a critical clinical dilemma: balancing the thrombotic risks of withdrawing antiplatelet therapy against the hemorrhagic risks of continuing it during major urologic procedures. This work has informed perioperative management strategies for patients on dual antiplatelet regimens, contributing to safer surgical practices in high-risk populations. O’Halloran’s research underscores his commitment to evidence-based urology, bridging the gap between cardiovascular and surgical care. While his citation count reflects a focused, early-career impact, his findings have practical implications for reducing complications in robotic surgery. His contributions highlight the importance of individualized risk assessment in urologic oncology, making him a thoughtful voice in the evolving field of nephron-sparing surgery.